FACT, ARC, LYNX AND GUARDIAN BALLOON CORONARY DILATATION CATHETERS

FDA Premarket Approval P970052

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the fact(tm), arc(tm), lynx(tm) and guardian(tm) balloon coronary dilatation catheters. These devices are indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purposed of improving myocardial perfusion. The application includes authorization from endosoncis corp. , rancho cordova, ca, to incorporate information contained in its approved premarket approval application and related supplements for hte cathscanner(r) oracle(r) micro ptca catheter.

DeviceFACT, ARC, LYNX AND GUARDIAN BALLOON CORONARY DILATATION CATHETERS
Generic NameCatheters, Transluminal Coronary Angioplasty, Percutaneous
ApplicantENDOLOGIX, INC.
Date Received1997-11-04
Decision Date1998-02-20
Notice Date1998-03-20
PMAP970052
SupplementS
Product CodeLOX 
Docket Number98M-0162
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ENDOLOGIX, INC. 11 Studebaker irvine, CA 92618

Supplemental Filings

Supplement NumberDateSupplement Type
P970052Original Filing
S002 1997-11-19 Normal 180 Day Track
S001 1997-03-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.